AM-2389: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
AM-2389 | == AM-2389 == | ||
[[File:AM-2389_Structure.svg|thumb|right|Chemical structure of AM-2389]] | |||
AM- | |||
[[ | '''AM-2389''' is a synthetic cannabinoid that acts as a potent agonist of the [[cannabinoid receptor]]s. It is primarily used in scientific research to study the [[endocannabinoid system]] and its effects on various physiological processes. | ||
== | === Chemical Properties === | ||
AM-2389 | AM-2389 is a derivative of the [[tetrahydrocannabinol]] (THC) structure, which is the principal psychoactive constituent of [[cannabis]]. The chemical structure of AM-2389 is designed to enhance its affinity and selectivity for the cannabinoid receptors, particularly [[CB1 receptor|CB1]] and [[CB2 receptor|CB2]]. | ||
===Mechanism of Action=== | === Mechanism of Action === | ||
AM-2389 functions by binding to the cannabinoid receptors in the [[central nervous system]] and [[peripheral nervous system]]. This binding mimics the action of naturally occurring endocannabinoids, such as [[anandamide]] and [[2-arachidonoylglycerol]], leading to various physiological effects. The activation of these receptors by AM-2389 can influence [[neurotransmitter]] release, [[pain perception]], [[appetite]], and [[immune response]]. | |||
==Research Applications== | === Research Applications === | ||
AM-2389 is utilized in research to explore the therapeutic potential of cannabinoid receptor modulation. Studies have investigated its effects on [[pain management]], [[ | AM-2389 is utilized in research to explore the therapeutic potential of cannabinoid receptor modulation. Studies have investigated its effects on [[pain management]], [[neuroprotection]], and [[inflammation]]. Additionally, AM-2389 is used to understand the role of the endocannabinoid system in [[neurological disorders]] such as [[epilepsy]], [[multiple sclerosis]], and [[Parkinson's disease]]. | ||
==Safety and | === Safety and Toxicology === | ||
As a research chemical, AM-2389 is not approved for human consumption and is typically | As a research chemical, AM-2389 is not approved for human consumption. Its safety profile is not well-established, and it is typically handled in controlled laboratory settings. Researchers must adhere to strict safety protocols to prevent accidental exposure. | ||
==Related Pages== | == Related Pages == | ||
* [[Cannabinoid receptor]] | * [[Cannabinoid receptor]] | ||
* [[Endocannabinoid system]] | * [[Endocannabinoid system]] | ||
* [[Synthetic cannabinoids]] | * [[Synthetic cannabinoids]] | ||
* [[Tetrahydrocannabinol]] | * [[Tetrahydrocannabinol]] | ||
[[Category:Synthetic cannabinoids]] | [[Category:Synthetic cannabinoids]] | ||
[[Category:Research chemicals]] | [[Category:Research chemicals]] | ||
Latest revision as of 03:34, 13 February 2025
AM-2389[edit]
AM-2389 is a synthetic cannabinoid that acts as a potent agonist of the cannabinoid receptors. It is primarily used in scientific research to study the endocannabinoid system and its effects on various physiological processes.
Chemical Properties[edit]
AM-2389 is a derivative of the tetrahydrocannabinol (THC) structure, which is the principal psychoactive constituent of cannabis. The chemical structure of AM-2389 is designed to enhance its affinity and selectivity for the cannabinoid receptors, particularly CB1 and CB2.
Mechanism of Action[edit]
AM-2389 functions by binding to the cannabinoid receptors in the central nervous system and peripheral nervous system. This binding mimics the action of naturally occurring endocannabinoids, such as anandamide and 2-arachidonoylglycerol, leading to various physiological effects. The activation of these receptors by AM-2389 can influence neurotransmitter release, pain perception, appetite, and immune response.
Research Applications[edit]
AM-2389 is utilized in research to explore the therapeutic potential of cannabinoid receptor modulation. Studies have investigated its effects on pain management, neuroprotection, and inflammation. Additionally, AM-2389 is used to understand the role of the endocannabinoid system in neurological disorders such as epilepsy, multiple sclerosis, and Parkinson's disease.
Safety and Toxicology[edit]
As a research chemical, AM-2389 is not approved for human consumption. Its safety profile is not well-established, and it is typically handled in controlled laboratory settings. Researchers must adhere to strict safety protocols to prevent accidental exposure.
